Skip to content

ETERNITY HEALTHCARE INC.: 10-Q filed 2016-12-13

What ETERNITY HEALTHCARE INC. reported in its quarterly report filed 2016-12-13 (fiscal Q2 2017): 22 published measures, 62 facts as tagged in accession 0001213900-16-019388.

This filing

Form
10-Q (quarterly report)
Filed
2016-12-13
Fiscal period
fiscal Q2 2017
Accession
0001213900-16-019388 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All ETERNITY HEALTHCARE INC. filings.

Reported measures

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-10-31-689,726USD
At 2016-04-30-516,213USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-10-31325,690USD
At 2016-04-30259,040USD
At 2015-10-31561,106USD
At 2015-07-31436,917USD
At 2015-04-30414,147USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-08-01 to 2016-10-31-116,174USD92
2016-05-01 to 2016-10-31-219,607USD184
2015-08-01 to 2015-10-31-101,169USD92
2015-05-01 to 2015-10-31-180,201USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2016-05-01 to 2016-10-31-211,446USD184
2015-05-01 to 2015-10-31-138,659USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-08-01 to 2016-10-31560USD92
2016-05-01 to 2016-10-312,733USD184
2015-08-01 to 2015-10-3125,394USD92
2015-05-01 to 2015-10-3131,688USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2016-05-01 to 2016-10-31-14,094USD184
2015-05-01 to 2015-10-31309,737USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2016-05-01 to 2016-10-31306,739USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-10-31-2,330,429USD
At 2016-04-30-2,110,822USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-08-01 to 2016-10-31-105,242USD92
2016-05-01 to 2016-10-31-198,103USD184
2015-08-01 to 2015-10-31-89,505USD92
2015-05-01 to 2015-10-31-158,121USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-10-31380,522USD
At 2016-04-30618,618USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-10-311,070,248USD
At 2016-04-301,134,831USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-08-01 to 2016-10-31105,614USD92
2016-05-01 to 2016-10-31199,785USD184
2015-08-01 to 2015-10-31104,609USD92
2015-05-01 to 2015-10-31176,924USD184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-10-3130,283USD
At 2016-04-303,064USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-08-01 to 2016-10-31372USD92
2016-05-01 to 2016-10-311,682USD184
2015-08-01 to 2015-10-3115,104USD92
2015-05-01 to 2015-10-3118,803USD184

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-08-01 to 2016-10-311,918USD92
2016-05-01 to 2016-10-3121,916USD184
2015-08-01 to 2015-10-3133,050USD92
2015-05-01 to 2015-10-3133,050USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-10-3166,429,868shares
At 2016-04-3066,429,868shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2016-10-311,539,591USD
At 2016-04-301,539,591USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2016-10-3134,682USD
At 2016-04-30-11,412USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2016-08-01 to 2016-10-3147,117USD92
2016-05-01 to 2016-10-3168,583USD184
2015-08-01 to 2015-10-3123,879USD92
2015-05-01 to 2015-10-3151,295USD184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

PeriodValueUnitDays
2016-08-01 to 2016-10-31-10,932USD92
2016-05-01 to 2016-10-31-21,504USD184
2015-08-01 to 2015-10-31-11,664USD92
2015-05-01 to 2015-10-31-22,080USD184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-05-01 to 2016-10-31-1,376USD184
2015-05-01 to 2015-10-31-4,761USD184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-05-01 to 2016-10-3126,645USD184
2015-05-01 to 2015-10-31-8,721USD184

Inspect the source

Entity
ETERNITY HEALTHCARE INC. / CIK 0001437822
Captured
SEC response SHA-256
35d5bef516124e2db5b4e453c5629c1c21f903d8cbf34c16cb85424604a332ea

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001437822.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))